Analytical Data
-
Gene name
APLN
- Application
-
Alternative Names
APLN；APEL；Apelin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9ULZ1
-
Expression Region
42-77aa
-
AA Sequence
LVQPRGSRN GPGPWQGGRR KFRRQRPRLS HKGPMPF
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
APLN, or apelin, is a bioactive peptide that plays a significant role in various physiological processes, including cardiovascular function, appetite regulation, and glucose metabolism. Research into APLN and its receptor, APJ, has gained momentum due to their involvement in numerous pathophysiological conditions, such as obesity, diabetes, and heart failure. In recent years, recombinant protein technology has been utilized to produce APLN for both therapeutic and research purposes. By genetically engineering host cells to express APLN, scientists can obtain large quantities of this peptide for detailed studies into its functional mechanisms and interactions within the body. The ability to produce recombinant APLN not only aids in understanding its role in cellular signaling pathways but also helps in exploring potential therapeutic applications, such as developing APLN-based drugs to target metabolic disorders or cardiovascular diseases. Overall, the study of recombinant APLN holds promise for advancing knowledge in peptide biology and improving clinical outcomes for individuals suffering from related health issues.
